Quadrant Capital Group’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-947
| Closed | -$4K | – | 2484 |
|
|
2021
Q2 | $4K | Buy |
+947
| New | +$4K | ﹤0.01% | 1890 |
|
|
2020
Q3 | – | Sell |
-3,315
| Closed | -$45K | – | 2151 |
|
|
2020
Q2 | $45K | Buy |
+3,315
| New | +$45K | 0.01% | 760 |
|
|
2018
Q3 | – | Sell |
-3,315
| Closed | -$33K | – | 2126 |
|
|
2018
Q2 | $33K | Hold |
3,315
| – | – | 0.01% | 790 |
|
|
2018
Q1 | $31K | Buy |
+3,315
| New | +$31K | 0.01% | 788 |
|